TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Steris ( (STE) ) has shared an update.
On July 31, 2025, STERIS announced the resignation of Michael J. Tokich as Chief Financial Officer, effective August 18, 2025, with Karen Burton appointed as his successor. This transition is part of a broader strategic shift, including a strong financial performance in the first quarter of fiscal 2026, with a 9% increase in total revenue and improved earnings per share. The company also updated its fiscal 2026 outlook, anticipating an 8-9% revenue increase due to favorable foreign currency conditions, despite challenges like tariffs and healthcare costs. Additionally, STERIS’s annual meeting saw the election of new board members and the approval of various shareholder proposals, reflecting strong shareholder engagement and strategic alignment.
The most recent analyst rating on (STE) stock is a Hold with a $263.00 price target. To see the full list of analyst forecasts on Steris stock, see the STE Stock Forecast page.
Spark’s Take on STE Stock
According to Spark, TipRanks’ AI Analyst, STE is a Outperform.
Steris’s overall score of 71 reflects a strong financial foundation and positive earnings outlook, despite technical weakness and valuation concerns. The company’s robust revenue growth and strategic management of margins support investor confidence, while challenges such as increasing debt and external cost pressures require attention.
To see Spark’s full report on STE stock, click here.
More about Steris
STERIS is a leading global provider of products and services focused on infection prevention, supporting patient care with innovative healthcare and life science solutions worldwide.
Average Trading Volume: 636,109
Technical Sentiment Signal: Buy
Current Market Cap: $22.02B
See more data about STE stock on TipRanks’ Stock Analysis page.